Litcius/Paper detail

Phospho-Ser784-VCP Is Required for DNA Damage Response and Is Associated with Poor Prognosis of Chemotherapy-Treated Breast Cancer

Cuige Zhu, Anna Rogers, Karama Asleh, Jennifer Won, Dongxia Gao, Samuel Leung, Shan Li, Kiran Vij, Jian Zhu, Jason M. Held, Zhongsheng You, Torsten O. Nielsen, Jieya Shao

2020Cell Reports33 citationsDOIOpen Access PDF

Abstract

phosphorylation is a DDR-specific enhancer of VCP function and a potential predictive biomarker for chemotherapy treatments.

Topics & Concepts

DNA damageChromatinDNA repairProteostasisBiologyCancer researchBreast cancerPhosphorylationChromatin remodelingCancerCell biologyDNABiochemistryGeneticsEndoplasmic Reticulum Stress and DiseaseUbiquitin and proteasome pathwaysDNA Repair Mechanisms
Phospho-Ser784-VCP Is Required for DNA Damage Response and Is Associated with Poor Prognosis of Chemotherapy-Treated Breast Cancer | Litcius